DISCOUNT-ZERTIFIKAT - APOS PHAR Stock

Certificat

DE000DW8RMF9

Delayed Deutsche Boerse AG 06:34:31 2024-07-03 EDT
5.66 EUR +0.89% Intraday chart for DISCOUNT-ZERTIFIKAT - APOS PHAR
Current month-0.36%
1 month+1.08%
Date Price Change
24-07-03 5.66 +0.89%
24-07-02 5.61 -0.36%
24-07-01 5.63 0.00%
24-06-28 5.63 0.00%
24-06-27 5.63 +0.36%

Delayed Quote Deutsche Boerse AG

Last update July 03, 2024 at 06:34 am

More quotes

Static data

Product typeCertificats Discount
Buy / SellCALL
Underlying APONTIS PHARMA AG
Issuer DZ BANK
WKN DW8RMF
ISINDE000DW8RMF9
Date issued 2022-12-29
Cap 6
Last trading day 2024-12-20
Maturity 2024-12-20 (171 Days)
Parity 1 : 1
Emission price 5.22
Emission volume N/A
Payment day 2024-12-31
Bonus-
Settlement règlement en espèces
Currency EUR

Technical Indicators

Discount (ask) 0.000000 %
Sideways yield 0.000000 %
Sideways yield pa 0.000000 %
Outperformance point-
Break even 0.000000 €
Highest since issue 5.68
Lowest since issue 2.99
Spread 0.05
Spread %0.88%
Distance Cap 2.43
Distance Cap %+28.83%
Max. earning-
Max. earning % 0.000000 %

Company Profile

Apontis Pharma AG is a Germany-based manufacturer of pharmaceutical preparation. The company focuses on the commercialization of pharmaceutical products to General Practitioners and engages in the marketing and sale of medical drugs for indication fields of internal medicine in Germany.
Sector
-
More about the company

Ratings for Apontis Pharma AG

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Consensus: Apontis Pharma AG

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
8.4 EUR
Average target price
17.38 EUR
Spread / Average Target
+106.85%
Consensus